blindness from glp 1 Doctor Explains Risk (Should You Be Worried?) Ozempic Vision Lawsuit | Attorneys

In June 2026, the FDA updated the OTC weight loss drug alli (orlistat) label to include a warning about the rare risk of kidney stones and acute kidney injury

The study population was mostly white (83%), with a median BMI of 37 kg/m 2 and a median NT-proBNP level of 493 pg/ml, and 33% of the patients had concomitant SGLTi use

People without obesity will continue to need joint replacements at the same rate as before

This is the same physiologic process seen when someone stops lifting weights: muscle size decreases because the stimulus is gonenot because muscle is being destroyed. Common Misconception: GLP-1 Drugs Burn Muscle Reality: Muscle loss during GLP-1associated weight loss is driven by reduced mechanical load and insufficient protein/calories , not by a toxic or catabolic drug effect. When Lean-Mass Loss Becomes True Muscle Wasting True muscle wasting is uncommon with GLP-1 therapy and is usually related to undernutrition , not the medication itself

People are filing gastroparesis lawsuits after taking GLP-1 drugs that led to hospitalization for stomach paralysis